Villa-Bellosta R
Int J Mol Sci. 2021; 22(24).
PMID: 34948333
PMC: 8708352.
DOI: 10.3390/ijms222413536.
Leyens J, Bender T, Mucke M, Stieber C, Kravchenko D, Dernbach C
Orphanet J Rare Dis. 2021; 16(1):326.
PMID: 34294115
PMC: 8296612.
DOI: 10.1186/s13023-021-01945-8.
Cudrici C, Newman K, Ferrante E, Huffstutler R, Carney K, Betancourt B
Rheumatology (Oxford). 2021; 61(1):163-173.
PMID: 33744914
PMC: 8742829.
DOI: 10.1093/rheumatology/keab270.
Couto A, Parreira B, Thomson R, Soares M, Power D, Stankovich J
Hum Genome Var. 2017; 4:17041.
PMID: 29104755
PMC: 5666909.
DOI: 10.1038/hgv.2017.41.
Liu M, Sun C, Yao Y, Fan X, Liu H, Cui Y
Sci Rep. 2016; 6:25401.
PMID: 27142968
PMC: 4855171.
DOI: 10.1038/srep25401.
Vascular Calcification Revisited: A New Perspective for Phosphate Transport.
Villa-Bellosta R
Curr Cardiol Rev. 2015; 11(4):341-351.
PMID: 26242187
PMC: 4774640.
DOI: 10.2174/1573403X11666150805120505.
Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes.
Bessueille L, Magne D
Cell Mol Life Sci. 2015; 72(13):2475-89.
PMID: 25746430
PMC: 11113748.
DOI: 10.1007/s00018-015-1876-4.
The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: results of a case-control study.
Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M
Arthritis Res Ther. 2014; 16(1):R25.
PMID: 24467728
PMC: 3978851.
DOI: 10.1186/ar4453.
Treatment and management of pseudogout: insights for the clinician.
MacMullan P, McCarthy G
Ther Adv Musculoskelet Dis. 2012; 4(2):121-31.
PMID: 22870500
PMC: 3383522.
DOI: 10.1177/1759720X11432559.
Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models.
Zhou X, Cui Y, Zhou X, Han J
Int J Biol Sci. 2012; 8(6):778-90.
PMID: 22719218
PMC: 3372882.
DOI: 10.7150/ijbs.4538.
Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia.
Gruber B, Couto A, Bruges Armas J, Brown M, Finzel K, Terkeltaub R
J Clin Rheumatol. 2012; 18(4):192-5.
PMID: 22647861
PMC: 4362680.
DOI: 10.1097/RHU.0b013e3182582c3d.
Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression.
Zhao G, Xu M, Zhao M, Dai X, Kong W, Wilson G
Kidney Int. 2012; 82(1):34-44.
PMID: 22437419
PMC: 3376207.
DOI: 10.1038/ki.2012.40.
Genetics and mechanisms of crystal deposition in calcium pyrophosphate deposition disease.
Tsui F
Curr Rheumatol Rep. 2011; 14(2):155-60.
PMID: 22198832
DOI: 10.1007/s11926-011-0230-6.
Two novel large ANKH deletion mutations in sporadic cases with craniometaphyseal dysplasia.
Dutra E, Chen I, McGregor T, Ranells J, Reichenberger E
Clin Genet. 2011; 81(1):93-5.
PMID: 22150416
PMC: 3417334.
DOI: 10.1111/j.1399-0004.2011.01700.x.
Investigating ANKH and ENPP1 in Slovakian families with chondrocalcinosis.
Couto A, Zhang Y, Timms A, Bruges-Armas J, Sequeiros J, Brown M
Rheumatol Int. 2011; 32(9):2745-51.
PMID: 21811784
DOI: 10.1007/s00296-011-2022-8.
[Crystal arthropathies].
Fuerst M, Zustin J, Ruther W
Pathologe. 2011; 32(3):193-9.
PMID: 21512754
DOI: 10.1007/s00292-011-1422-6.
Pathophysiology of articular chondrocalcinosis--role of ANKH.
Abhishek A, Doherty M
Nat Rev Rheumatol. 2010; 7(2):96-104.
PMID: 21102543
DOI: 10.1038/nrrheum.2010.182.
Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family.
Morava E, Kuhnisch J, Drijvers J, Robben J, Cremers C, van Setten P
J Clin Endocrinol Metab. 2010; 96(1):E189-98.
PMID: 20943778
PMC: 5393418.
DOI: 10.1210/jc.2010-1539.
[Osteoarthritis in hereditary metabolic diseases].
Zwerina J, Dallos T
Orthopade. 2010; 39(6):637-46.
PMID: 20559790
DOI: 10.1007/s00132-010-1646-9.
[Osteoarthritis in hereditary metabolic diseases].
Zwerina J, Dallos T
Z Rheumatol. 2010; 69(3):227-35.
PMID: 20300760
DOI: 10.1007/s00393-009-0590-8.